Cancer screening in myositis:
the path has always been unclear and inconsistent
Workable consensus recommendations @Dr_Alex_Oldroyd
risk stratification but still extensive investigation burden for most
now need to look at effectiveness including cost
ABST0002 #ACR22 @RheumNow
the path has always been unclear and inconsistent
Workable consensus recommendations @Dr_Alex_Oldroyd
risk stratification but still extensive investigation burden for most
now need to look at effectiveness including cost
ABST0002 #ACR22 @RheumNow
